Year archive

Middle East Pharmaceutical Industries Co. — 2026 filings

All 15 regulatory filings released by Middle East Pharmaceutical Industries Co. (4016) in 2026, sourced directly from the official regulator.

15 Filings

2026 Period

2026 filings (15)

Filing	Released	Lang
Middle East Pharmaceutical Industries Co. announces the deposit of the amounts from selling the shares fractions resulted from the company’s capital Increase in the eligible shareholder’s accounts Share Issue/Capital Change	2026-05-31	English
Middle East Pharmaceutical Industries Co. Announces the Results of the Extraordinary General Assembly’s Meeting Included the Approval of the Company’s Capital Increase. (First Meeting) Declaration of Voting Results & Voting Rights Announcements	2026-05-12	English
Middle East Pharmaceutical Industries Co. announces its Interim Financial results for the Period Ending on 2026-03-31 (Three Months) Interim / Quarterly Report Q1 2026	2026-05-06	English
Correction announcement from Middle East Pharmaceutical Industries Co. in regards to the Details of the Electronic Voting Feature on the Agenda Items of the Extraordinary General Assembly. Regulatory Filings	2026-04-21	English
Middle East Pharmaceutical Industries Co. calls its shareholders to attend the Extraordinary General Assembly meeting which include the Increase of the company’s capital ( First Meeting ) Proxy Solicitation & Information Statement	2026-04-20	English
Middle East Pharmaceutical Industries Co. Announces the formation of its Audit Committee. Board/Management Information	2026-04-16	English
Middle East Pharmaceutical Industries Co. Announces the appointment of the Chairman and Vice Chairman of the Board, the formation of the Board’s Committees, and the appointment of the Board’s Secretar Board/Management Information	2026-04-16	English
Middle East Pharmaceutical Industries Co. Announces the Results of the Ordinary General Assembly Meeting (First Meeting) Declaration of Voting Results & Voting Rights Announcements	2026-04-12	English
Middle East Pharmaceutical Industries Co. Board invites its shareholders to attend the Ordinary General Assembly Meeting the (First Meeting) AGM Information	2026-03-16	English
Middle East Pharmaceutical Industries Co. announces the board of director’s decision to distribute cash dividends for the second half of 2025. Notice of Dividend Amount	2026-03-08	English
Middle East Pharmaceutical Industries Co. announces its Annual Financial results for the period ending on 2025-12-31 Annual Report FY 2025	2026-03-04	English
Addendum Announcement from Middle East Pharmaceutical Industries Co. in regards to Contract Sign Off with Bio-Thera Solutions Inc. Regulatory Filings	2026-02-04	English
Middle East Pharmaceutical Industries Co. Announces Contract Sign Off with Bio-Thera Solutions Inc. A global biopharmaceutical company specializing in innovative biologics and biosimilars Capital/Financing Update	2026-02-04	English
Middle East Pharmaceutical Industries Co. Announces the Board’s Recommendation to Increase the Capital by Granting Bouns Shares Share Issue/Capital Change	2026-02-01	English
Middle East Pharmaceutical Industries Co. announces the opening of the nomination period for the board of director’s membership for next term. Board/Management Information	2026-01-04	English